However, compared to their studies, our study delves deeper into the molecular mechanisms underlying this process, particularly focusing on the phosphorylation-mediated regulation of FBXO11 and β-catenin, and the downstream effects on EMT and metastasis, shedding light on specific molecular pathways involved in prostate cancer progression. This evidence concerns the gene FBXO11 and prostate cancer.